Antidepressive treatment as a modulator of inflammatory process in patients with heart failure: Effects on proinflammatory cytokines and acute phase protein levels
- 15 May 2009
- journal article
- clinical trial
- Published by Elsevier BV in International Journal of Cardiology
- Vol. 134 (2), 238-243
- https://doi.org/10.1016/j.ijcard.2008.02.013
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Depression and Cardiovascular DiseaseJAMA, 2006
- Depressive Symptoms and 24-Hour Urinary Norepinephrine Excretion Levels in Patients With Coronary Disease: Findings From the Heart and Soul StudyAmerican Journal of Psychiatry, 2005
- The Medical Management of DepressionNew England Journal of Medicine, 2005
- Depression and ischemic heart disease: What have we learned so far and what must we do in the future?American Heart Journal, 2005
- Depressive symptoms and inflammation among heart failure patientsAmerican Heart Journal, 2005
- Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathyInternational Journal of Cardiology, 2004
- Anti-Inflammatory Effects of Antidepressants Through Suppression of the Interferon-γ/Interleukin-10 Production RatioJournal of Clinical Psychopharmacology, 2001
- Pathophysiological Role of Cytokines in Congestive Heart FailureAnnual Review of Medicine, 2001
- Cytokine Production and Treatment Response in Major Depressive DisorderNeuropsychopharmacology, 2000
- Negative Inotropic Effects of Cytokines on the Heart Mediated by Nitric OxideScience, 1992